Precision Diagnostics and Regenerative Medicine Industry Showcase: Collaborative Innovation Ignites the Future

The 2023 Taiwan Healthcare Expo will grandly open from November 30th to December 3rd. The "Innovative Medical Technology Industry Alliance Pavilion" will showcase Taiwan's innovative technologies and products in the fields of precision diagnostics and regenerative medicine.

The exhibition area is located at Booth M411a in the Precision Diagnostics & Grand Health Pavilion on the 4th floor of Nangang Exhibition Center Hall 1. It is initiated by Dr. Chu Chia-Jung, CEO of the renowned biomedical startup company SILICON-BASED MOLECULAR SENSORING TECHNOLOGY CO., LTD., and jointly exhibited with LABCHINA, GeniCore Biotech, LIS TECH, Medicare Products, 中一醫事檢驗所, and the Regenerative Medicine Cloud Alliance. The public will be able to witness firsthand the innovative power of Taiwan's biotech and medical industries.

SILICON-BASED MOLECULAR SENSORING TECHNOLOGY boasts world-leading semiconductor biomedical chip technology and will showcase its independently developed biomedical chips and the SENEDIA Pro fully automatic trace biomedical molecule detection system. Genicore Biotechn, with its exclusively developed nucleic acid screening and modification technology, will for the first time publicly present its achievements in applying aptamer probes for detection. LIS TECH is dedicated to developing Taiwan's local research brand, BIO-DOC, and will exhibit the ROKIT Healthcare 3D bioprinter, which has already been used in clinical trials for diabetic wound and cartilage repair. LABCHINA is an expert in precision medicine laboratory planning and construction, and also serves as the service center in the Asia-Pacific region for Austria's SY-LAB Bactrac® fully automated pathogenic bacteria and microorganism rapid detection system. Medicare Products has over 30 years of medical examination experience and software system development capabilities, offering optimal service solutions for laboratory hardware and software system integration in medical institutions. 中一醫事檢驗所 maintains high-quality medical testing standards, utilizing medical center-grade testing instruments to serve medical units at all levels across Taiwan.

The Regenerative Medicine Cloud Alliance is led by numerous companies including Chang Sheng Technology, Magdison Biomedical, Lumens Bio, Guangliang Bio, Celna Biomedical, Cen Hsiang, Tot, Toolgen Biotech, Ansin Biotech, ProKing Biotech, Airegen Biotech, GeneSpark Biotech, Sciencoo Bio, and Tian Ming Pharmaceuticals. This alliance is dedicated to providing comprehensive support from facilities to materials, aiming to foster close industry chain connections and collaborations to accelerate the growth and innovation of startups. This strategy will provide crucial resources and support for startups, helping them overcome the challenges of early-stage entrepreneurship.

The 2022 innovative cross-disciplinary joint exhibition attracted significant attention from professionals and the public. (Image provided by the Innovative Medical Technology Industry Alliance)

This meticulously curated joint exhibition will present the forefront of innovative medical technology to the public, offering the best opportunity to explore Taiwan's cutting-edge biotech and medical technologies. It's particularly noteworthy that in this exhibition, the Innovative Medical Technology Industry Alliance will highlight its integrated achievements. Through the latest technologies and product services from each participating company, the alliance will share its collaborative model and vision with the public, demonstrating Taiwan's strengths in precision medicine and regenerative medicine.

Source: Commercial Times

https://www.ctee.com.tw/news/20231129701648-431205